Tom Mahoney is a distinguished investor and philanthropist in the field of Immunology and Infectious Diseases, currently affiliated with the prestigious Harvard T.H. Chan School of Public Health Department of Immunology and Infectious Diseases. Tom's work is characterized by a deep commitment to public health and a passion for advancing scientific knowledge in the field of immunology. As an investor he is focused ion translating cutting-edge research into practical solutions that can have a real-world impact on disease prevention and control. Tom seeks to forge and fund collaborative approaches to research and global strategic partnerships leading to groundbreaking discoveries and advancements in vaccine technology.
As a speaker at the World Vaccine Congress Washington 2026, Tom Mahoney will share his insights and expertise on the role of venture philanthropy in strategic partnering in the global vaccine industry. Attendees can expect to gain valuable knowledge from his panel, informed by years of experience and a dedication to driving innovation in vaccine development.